Regulus Therapeutics
RGLS
#8339
Rank
โ‚ฌ0.10 B
Marketcap
1,64ย โ‚ฌ
Share price
6.43%
Change (1 day)
35.69%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ93.95 M

According to Regulus Therapeutics's latest financial reports the company's total assets are โ‚ฌ93.95 M. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2022-12-31โ‚ฌ43.55 M-27.62%
2021-12-31โ‚ฌ60.16 M95.59%
2020-12-31โ‚ฌ30.76 M-17.92%
2019-12-31โ‚ฌ37.47 M53.73%
2018-12-31โ‚ฌ24.37 M-62.41%
2017-12-31โ‚ฌ64.84 M-32.24%
2016-12-31โ‚ฌ95.69 M-25.95%
2015-12-31โ‚ฌ0.12 B-8.26%
2014-12-31โ‚ฌ0.14 B58.14%
2013-12-31โ‚ฌ89.08 M13.74%
2012-12-31โ‚ฌ78.32 M137.2%
2011-12-31โ‚ฌ33.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ66.29 B 70,461.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ125.51 B 133,492.33%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ24.18 B 25,643.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ94.15 B 100,112.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ3.61 B 3,751.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.93 M-10.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ85.40 B 90,801.76%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA